The D-Flex injection pen can do more than previous pens. D-Flex can be configured for...
Konrad Betzler was appointed the new chief quality officer (CQO) of the entire Haselmeier Group in October 2017, with responsibility for quality management, quality assurance, and all regulatory matters worldwide.
As a member of the Group Executive Board, he continues to lead the Pharmaceutical Manufacturing division as chief pharmaceutical officer (CPO).
Former CQO Dr. Bernhard Kraus decided to quit his job at Haselmeier after two years with the Haselmeier Group for personal reasons and to accept new challenges. The Haselmeier team would like to thank him for his committed and successful work in the stabilisation and further development of the company’s global quality management system and wishes him all the best on his further journey.
As CPO in the senior leadership team and as a future Qualified Person responsible for the development of pharmaceutical production at the site in Buchen, Mr. Konrad Betzler took on the position of CQO on 1 October. This gives Haselmeier the unique opportunity to bundle and structure the requirements for the quality management system in one function from the perspective of medical device and drug manufacturing.
As a manufacturer of medical devices, Haselmeier is once again adapting to the increasing demands of the market for combination products and thus qualifies further in the direction of strategic partners for its customers in the pharmaceutical industry.
Although both the medical device and the pharmaceutical industry have different pronouncements, both work in the same process and compliance worlds: rule-based, very structured, facts-based, and transparent. With this step, Haselmeier will help exploit the synergetic potential of combination products and further expand the accompanying quality assurance systems as an integrated partner for its customers.
Based on this consideration, Mr. Betzler also derives his priorities for the next few months:
- Further developing and integrating the various processes of the quality management system into a holistic, global approach
- The sustainable implementation of quality indicators as a basis for management decisions
- The regular exchange with the customers regarding expectations and experiences with Haselmeier.
Mr. Konrad Betzler is looking forward to the personal exchange with his quality management colleagues of our customers. Corresponding appointments are currently active.
Type 2 diabetes is a global health problem. According to expert estimates, the number of...
Haselmeier Acquires Drug Manufacturing Licence and Now Offers Assembly, Labelling Packaging Services
As an innovative, strategic partner company, Haselmeier develops and produces customised, unique systems that are...
Haselmeier and smart injector monitoring and support solutions company Common Sensing have announced a partnership...